中南大学学报(医学版)
中南大學學報(醫學版)
중남대학학보(의학판)
JOURNAL OF CENTRAL SOUTH UNIVERSITY (MEDICAL SCIENCES)
2006年
3期
313-317
,共5页
杨进福%周文武%唐滔%胡建国%喻杰锋%杨一峰%周新民%胡冬煦
楊進福%週文武%唐滔%鬍建國%喻傑鋒%楊一峰%週新民%鬍鼕煦
양진복%주문무%당도%호건국%유걸봉%양일봉%주신민%호동후
骨髓间充质干细胞%分化%转染%血管内皮生长因子
骨髓間充質榦細胞%分化%轉染%血管內皮生長因子
골수간충질간세포%분화%전염%혈관내피생장인자
mesenchymal stem cells%differentiation%transfection%vascular endothelial growth factor
目的:建立人血管内皮生长因子165(hVEGF165)基因转染大鼠骨髓间充质干细胞的方法.方法:采用密度梯度离心-贴壁培养法获Wistar大鼠骨髓间充质干细胞(MSCs),测定其生长曲线和表面标志CD34,CD44,CD45及SH3,检测其向成骨细胞及脂肪细胞诱导分化潜能后;用脂质体介导法将pcDNA3.1-hVEGF165导入MSCs,观察转染后细胞形态和生长状况,通过RT-PCR,Western blot和ELISA鉴定VEGF在MSCs中的表达情况.结果:大鼠MSCs经检测为CD44和SH3阳性,CD45和CD34阴性,可诱导分化为成骨细胞和脂肪细胞;经RT-PCR,Western和ELISA检测证实阳离子脂质体能成功地将hVEGF165转染至大鼠MSCs,并获得有效的表达.结论:真核表达载体pcDNA3.1-VEGF165在MSCs中获有效表达.
目的:建立人血管內皮生長因子165(hVEGF165)基因轉染大鼠骨髓間充質榦細胞的方法.方法:採用密度梯度離心-貼壁培養法穫Wistar大鼠骨髓間充質榦細胞(MSCs),測定其生長麯線和錶麵標誌CD34,CD44,CD45及SH3,檢測其嚮成骨細胞及脂肪細胞誘導分化潛能後;用脂質體介導法將pcDNA3.1-hVEGF165導入MSCs,觀察轉染後細胞形態和生長狀況,通過RT-PCR,Western blot和ELISA鑒定VEGF在MSCs中的錶達情況.結果:大鼠MSCs經檢測為CD44和SH3暘性,CD45和CD34陰性,可誘導分化為成骨細胞和脂肪細胞;經RT-PCR,Western和ELISA檢測證實暘離子脂質體能成功地將hVEGF165轉染至大鼠MSCs,併穫得有效的錶達.結論:真覈錶達載體pcDNA3.1-VEGF165在MSCs中穫有效錶達.
목적:건립인혈관내피생장인자165(hVEGF165)기인전염대서골수간충질간세포적방법.방법:채용밀도제도리심-첩벽배양법획Wistar대서골수간충질간세포(MSCs),측정기생장곡선화표면표지CD34,CD44,CD45급SH3,검측기향성골세포급지방세포유도분화잠능후;용지질체개도법장pcDNA3.1-hVEGF165도입MSCs,관찰전염후세포형태화생장상황,통과RT-PCR,Western blot화ELISA감정VEGF재MSCs중적표체정황.결과:대서MSCs경검측위CD44화SH3양성,CD45화CD34음성,가유도분화위성골세포화지방세포;경RT-PCR,Western화ELISA검측증실양리자지질체능성공지장hVEGF165전염지대서MSCs,병획득유효적표체.결론:진핵표체재체pcDNA3.1-VEGF165재MSCs중획유효표체.
Objective To create a method for transfecting human vascular endothelial growth factor165 (hVEGF165) gene into bone marrow mesenchymal stem cells (MSCs) in rats. Methods MSCs of Wistar rats were isolated by density gradient centrifugation and purified based on their ability of adhesion to plastic. Detections of cell surface antigens, including CD34, CD45, CD44, and SH3, were performed using flow cytometry. MSCs' potential of differentiating into osteoblast and lipoblast in vitro was tested. The vector pcDNA3.1-hVEGF165 was transfected into MSCs with the liposome mediated method. The expression of hVEGF165 in the transfected cells was detected by enzyme linked immunosorbent assay (ELISA), reverse transcription-polymerase chain reaction (RT-PCR), and Western blot analysis. Results The cultured MSCs were CD34-, CD45-, CD44+, and SH+, which were differentiated into osteoblasts and lipocytes successfully. The expressed hVEGF165 in the transfected rat MSCs was demonstrated. Conclusion The vector pcDNA3.1-hVEGF165 is successfully expressed in MSCs.